Sign Up to like & get
recommendations!
0
Published in 2024 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s450305
Abstract: Introduction Tacrine, an FDA-approved acetylcholinesterase inhibitor, has shown efficacy in treating Alzheimer’s disease, but its clinical use is limited by hepatotoxicity. This study investigates the protective effects of red ginseng against tacrine-induced hepatotoxicity, focusing on…
read more here.
Keywords:
protective effects;
tacrine induced;
pharmacology;
induced hepatotoxicity ... See more keywords